clorazepate dipotassium has been researched along with Substance Withdrawal Syndrome in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (73.33) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 2 (13.33) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bires, K; Kim, E; Nayak, S; Rawls, SM; Roberts, A; Tallarida, CS; Wu, M | 1 |
| Capasso, A; Cavallo, F; Raffa, RB | 1 |
| Capasso, A; Cavallo, F; Ding, Z; Raffa, RB; Rawls, SM | 1 |
| Greenblatt, DJ; Shader, RI | 1 |
| Simon, P | 1 |
| Sussman, N | 1 |
| Gallant, DM; McFarlain, RA; Mielke, DH | 1 |
| Allgulander, C; Borg, S | 1 |
| Keeler, MH; Miller, WC | 1 |
| De Bellis, M; Devinsky, O; Hauser, P; Post, RM; Theodore, WH | 1 |
| Fox, IL; Greenblatt, DJ; Rickels, K; Sandler, KR; Schless, A | 1 |
| Case, WG; Chung, H; Csanalosi, I; Rickels, K; Schweizer, E | 1 |
| Daghestani, AN | 1 |
| Case, WG; Downing, RW; Rickels, K; Winokur, A | 1 |
3 review(s) available for clorazepate dipotassium and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
The use of benzodiazepines in clinical practice.
Topics: Anti-Anxiety Agents; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Humans; Kinetics; Lorazepam; Metabolic Clearance Rate; Oxazepam; Prazepam; Substance Withdrawal Syndrome | 1981 |
Treating anxiety while minimizing abuse and dependence.
Topics: Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Buspirone; Clorazepate Dipotassium; Humans; Substance Withdrawal Syndrome; Substance-Related Disorders | 1993 |
Selection among benzodiazepines for alcohol withdrawal.
Topics: Administration, Oral; Benzodiazepines; Central Nervous System; Chlordiazepoxide; Clorazepate Dipotassium; Depression, Chemical; Diazepam; Drug Synergism; Ethanol; Half-Life; Humans; Oxazepam; Seizures; Substance Withdrawal Syndrome; Time Factors | 1977 |
4 trial(s) available for clorazepate dipotassium and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Clorazepate dipotassium (Tranxene): a controlled evaluation in alcoholic patients after withdrawal.
Topics: Adult; Alcoholism; Anti-Anxiety Agents; Anxiety; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Humans; Middle Aged; Placebos; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1976 |
Clorazepate and lorazepam: clinical improvement and rebound anxiety.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Female; Half-Life; Humans; Lorazepam; Male; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1988 |
Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
Topics: Adult; Anti-Anxiety Agents; Anxiety Disorders; Buspirone; Clinical Trials as Topic; Clorazepate Dipotassium; Double-Blind Method; Drug Tolerance; Female; Humans; Male; Outcome and Process Assessment, Health Care; Panic; Patient Compliance; Patient Dropouts; Personality Inventory; Prospective Studies; Psychiatric Status Rating Scales; Substance Withdrawal Syndrome | 1988 |
Indications and contraindications for chronic anxiolytic treatment: is there tolerance to the anxiolytic effect?
Topics: Anxiety; Chronic Disease; Clinical Trials as Topic; Clorazepate Dipotassium; Diazepam; Double-Blind Method; Drug Tolerance; Humans; Lorazepam; Substance Withdrawal Syndrome | 1985 |
8 other study(ies) available for clorazepate dipotassium and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Benzodiazepine inhibits anxiogenic-like response in cocaine or ethanol withdrawn planarians.
Topics: Animals; Anti-Anxiety Agents; Behavior, Animal; Benzodiazepines; Clorazepate Dipotassium; Cocaine; Darkness; Dose-Response Relationship, Drug; Ethanol; Light; Planarians; Substance Withdrawal Syndrome; Time Factors | 2016 |
Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists.
Topics: Analysis of Variance; Animals; Benzodiazepines; Clorazepate Dipotassium; Dose-Response Relationship, Drug; Flumazenil; GABA Agonists; GABA Modulators; Locomotion; Midazolam; Planarians; Pyridines; Receptors, GABA-A; Reproducibility of Results; Substance Withdrawal Syndrome; Substance-Related Disorders; Zolpidem | 2007 |
The beta-lactam antibiotic ceftriaxone inhibits physical dependence and abstinence-induced withdrawal from cocaine, amphetamine, methamphetamine, and clorazepate in planarians.
Topics: Amphetamine; Amphetamine-Related Disorders; Animals; Anti-Bacterial Agents; Ceftriaxone; Clorazepate Dipotassium; Cocaine; Cocaine-Related Disorders; Dose-Response Relationship, Drug; Excitatory Amino Acid Transporter 2; Methamphetamine; Models, Animal; Motor Activity; Planarians; Substance Withdrawal Syndrome; Substance-Related Disorders; Time Factors | 2008 |
Antidepressants, benzodiazepines, and convulsions.
Topics: Adult; Anti-Anxiety Agents; Clorazepate Dipotassium; Female; Humans; Imipramine; Seizures; Substance Withdrawal Syndrome | 1983 |
Systematic review of the benzodiazepines. Guidelines for data sheets on diazepam, chlordiazepoxide, medazepam, clorazepate, lorazepam, oxazepam, temazepam, triazolam, nitrazepam, and flurazepam. Committee on the Review of Medicines.
Topics: Benzodiazepines; Chlordiazepoxide; Clorazepate Dipotassium; Diazepam; Flurazepam; Humans; Lorazepam; Medazepam; Nitrazepam; Oxazepam; Safety; Substance Withdrawal Syndrome; Substance-Related Disorders; Temazepam; Triazolam | 1980 |
Case report: a delirious abstinence syndrome associated with clorazepate (Tranxilen).
Topics: Adult; Anti-Anxiety Agents; Clorazepate Dipotassium; Delirium; Female; Humans; Substance Withdrawal Syndrome | 1978 |
Benzodiazepine withdrawal delirium with catatonic features. Occurrence in patients with partial seizure disorders.
Topics: Adult; Benzodiazepines; Catatonia; Clonazepam; Clorazepate Dipotassium; Delirium; Encephalitis; Female; Humans; Male; Seizures; Substance Withdrawal Syndrome; Virus Diseases | 1989 |
Alcohol withdrawal. A comprehensive approach to treatment.
Topics: Aftercare; Alcohol Withdrawal Delirium; Benzodiazepines; Clorazepate Dipotassium; Ethanol; Humans; Monitoring, Physiologic; Patient Education as Topic; Physician-Patient Relations; Substance Withdrawal Syndrome | 1987 |